135 related articles for article (PubMed ID: 28298074)
1. Evaluation of growth inhibitory response of Resveratrol and Salinomycin combinations against triple negative breast cancer cells.
Rai G; Suman S; Mishra S; Shukla Y
Biomed Pharmacother; 2017 May; 89():1142-1151. PubMed ID: 28298074
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
Rai G; Mishra S; Suman S; Shukla Y
Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
[TBL] [Abstract][Full Text] [Related]
3. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
4. Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells.
Dewangan J; Tandon D; Srivastava S; Verma AK; Yapuri A; Rath SK
Apoptosis; 2017 Oct; 22(10):1246-1259. PubMed ID: 28748373
[TBL] [Abstract][Full Text] [Related]
5. Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy.
Zhang XF; Gurunathan S
Int J Nanomedicine; 2016; 11():3655-75. PubMed ID: 27536105
[TBL] [Abstract][Full Text] [Related]
6. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
7. A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis.
Venkatadri R; Iyer AKV; Kaushik V; Azad N
Pharmacol Rep; 2017 Aug; 69(4):788-797. PubMed ID: 28605700
[TBL] [Abstract][Full Text] [Related]
8. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
9. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
10. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
12. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells.
Alkhalaf M
Pharmacology; 2007; 80(2-3):134-43. PubMed ID: 17534123
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines.
He L; Wang F; Dai WQ; Wu D; Lin CL; Wu SM; Cheng P; Zhang Y; Shen M; Wang CF; Lu J; Zhou YQ; Xu XF; Xu L; Guo CY
Pancreatology; 2013; 13(1):72-8. PubMed ID: 23395573
[TBL] [Abstract][Full Text] [Related]
16. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
[TBL] [Abstract][Full Text] [Related]
17. An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells.
Zhang Z; Zhao J; Pang Q; Wang A; Chen M; Wei X
Mol Med Rep; 2017 Aug; 16(2):1031-1038. PubMed ID: 28627601
[TBL] [Abstract][Full Text] [Related]
18. An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells.
Chandrasekaran J; Balasubramaniam J; Sellamuthu A; Ravi A
J Pharm Pharmacol; 2021 Apr; 73(6):749-757. PubMed ID: 33769483
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line.
Aydinlik S; Erkisa M; Cevatemre B; Sarimahmut M; Dere E; Ari F; Ulukaya E
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):49-57. PubMed ID: 27842219
[TBL] [Abstract][Full Text] [Related]
20. Codelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitro.
Xie F; Zhang S; Liu J; Gong Z; Yang K; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Wang X; Zhang H; Zhang G; Li W; Li B; Gao J; Zhong Y
Nanomedicine (Lond); 2016 Jul; 11(14):1831-46. PubMed ID: 27391366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
